Mature results of MM-011: A phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study
Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies
Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters
Mutation analysis of a cohort of US patients with hemophilia B
Novel type of red blood cell pyruvate kinase hyperactivity predicts a remote regulatory locus involved in PKLR gene expression
Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15
Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload
Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy
Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse
Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation
Azacitidine in untreated acute myeloid leukemia: A report on 149 patients
Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein-10 predicts inferior prognosis in untreated diffuse large B-cell lymphoma
Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes
Follicular lymphoma: 2014 update on diagnosis and management
Azurophilic granules in myeloma cells
Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene
Haptoglobin testing in hemolysis: Measurement and interpretation
Cutaneous involvement by post-polycythemia vera myelofibrosis
CD75: A B-cell marker which should not be forgotten in lymphocyte predominant Hodgkin lymphoma
CALR mutation studies in chronic neutrophilic leukemia
Mortality from myelodysplastic syndromes: A multiple causes of death approach